What is the current Blood Cell Separation Membrane market size?

The Blood Cell Separation Membrane market size reached USD 1.2 billion in 2023, driven by advancements in filtration technologies and rising demand for plasma-derived therapies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% through 2033, fueled by expansion in biopharmaceutical applications and increasing blood donation initiatives.

What are the key drivers of market growth?

Key drivers include rising adoption in dialysis and immunotherapy, growing R&D investments in regenerative medicine, and enhanced membrane efficiency in blood fractionation.

What challenges does the market face?

Challenges include stringent regulatory compliance, high production costs, and fluctuating raw material prices affecting membrane manufacturing.

Which regions are leading the market?

North America dominates the market, while Asia-Pacific shows the fastest growth due to improving healthcare infrastructure and rising chronic disease rates.

Who are the top companies in this sector?

Leading firms include Fresenius Medical Care, Asahi Kasei, Baxter International, and B. Braun Melsungen AG, focusing on R&D and strategic partnerships.

What future opportunities exist?

Opportunities lie in emerging markets, automation in membrane production, and innovations in point-of-care blood separation technologies.

How is technology impacting the market?

Advances in nanotechnology and AI-driven process optimization are enhancing membrane durability and separation accuracy, driving market competitiveness.

What is the regulatory landscape?

Regulatory frameworks by FDA, EMA, and ISO ensure safety and efficacy, while evolving standards for single-use systems present both compliance challenges and growth triggers.

Blood Cell Separation Membrane Growth Trends & Opportunity Analysis 2033

Blood Cell Separation Membrane by Application (Whole Blood Plasma Separation, Immunochromatographic Diagnosis, Microsomal Diagnostics, Others), by Types (for Volumes 10-15 µL, for Volumes 15-50 µL, for Volumes above 50 µL), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Blood Cell Separation Membrane Market Overview

The Blood Cell Separation Membrane market encompasses advanced filtration technologies used to isolate blood components for transfusion, research, and therapeutic applications. As a critical enabler of precision medicine and diagnostic advancements, the market is witnessing transformative shifts in healthcare. The Blood Cell Separation Membrane market size is projected to expand significantly through 2033, driven by rising demand for automated blood processing systems and innovations in membrane biotechnology. This market forecast highlights robust industry expansion, with strategic players leveraging R&D investments and regulatory tailwinds to capture emerging opportunities.

Loading chart…

With a compound annual growth rate (CAGR) of 6.8% expected from 2026–2033, the Blood Cell Separation Membrane market is shaped by three key forces: 1) Technological innovation in nanofiltration and microfluidic systems enhancing separation efficiency, 2) Regulatory alignment across regions to standardize medical device approvals, and 3) Supply-chain resilience amid global healthcare infrastructure modernization. North America dominates the market due to its established biotechnology sector, while Asia-Pacific is the fastest-growing region, fueled by expanding healthcare access and government-funded R&D initiatives. Strategic partnerships and vertical integration remain pivotal for competitive differentiation in this capital-intensive industry.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.11 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cytiva; Cobetter; Fortis Life Sciences; IW Tremont; Advanced Microdevices; Axiflow Biotech; Axivasi Chem; Pall
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Blood Cell Separation Membrane market size is expanding due to rising demand for precision therapies and personalized medicine, which require high-purity cell populations. Advanced membrane technologies, such as nanopore engineering, are enhancing separation efficiency, driving adoption in oncology and regenerative medicine.

Growth forecast for the Blood Cell Separation Membrane market is bolstered by increasing blood donation rates and advancements in automated blood processing systems. Regulatory incentives for blood safety in transplants further accelerate market penetration in developed regions.

Restraints2 items

High capital expenditures for membrane-based systems limit access in low-income markets, where cost-sensitive healthcare providers prioritize cheaper alternatives like centrifugation. This hampers the Blood Cell Separation Membrane market’s growth in emerging economies.

Stringent regulatory requirements for membrane sterility and performance testing delay product commercialization. Compliance costs create barriers for small manufacturers, reducing market competitiveness.

Opportunities2 items

The Asia-Pacific Blood Cell Separation Membrane market is poised for growth as governments invest in blood banking infrastructure to address shortages. Urbanization and rising awareness of blood donation campaigns are expanding the donor pool, fueling demand for separation technologies.

Emerging point-of-care (POC) diagnostic devices integrating miniaturized separation membranes present untapped revenue streams. These systems cater to decentralized healthcare settings, reducing reliance on centralized labs.

Challenges2 items

Fluctuating raw material prices for polymer-based membranes, such as polyethersulfone, increase production costs and strain profit margins. Supply chain disruptions exacerbate volatility in the Blood Cell Separation Membrane market.

Technological competition from non-membrane separation methods, such as acoustic or magnetic sorting, threatens market share. These alternatives offer faster processing times, compelling membrane manufacturers to innovate rapidly.

Market Segmentation

Loading chart…

Application segmentation in the Blood Cell Separation Membrane market reflects distinct medical and diagnostic usage patterns. Hemodialysis dominates with ~55% market share, driven by chronic kidney disease prevalence and the need for efficient blood purification. Blood transfusion applications account for ~30%, leveraging membranes to remove cellular components while preserving plasma. Diagnostic testing (15%) relies on membranes for cell isolation in research and clinical labs. These subcategories underscore functional diversity, with hemodialysis and transfusion driving clinical demand and diagnostics fueling innovation. The Blood Cell Separation Membrane segmentation by application highlights how end-use scenarios dictate membrane design, biocompatibility standards, and filtration efficiency requirements.

Types segmentation categorizes membranes by material composition, impacting performance and market adoption. Polyethersulfone (PES) membranes (65%) lead due to superior biocompatibility, high porosity, and resistance to protein fouling, making them ideal for dialysis and transfusion. Cellulose acetate membranes (35%) remain relevant in lower-cost applications but face limitations in durability and pore uniformity. Emerging materials like modified cellulose and polyvinylidene fluoride (PVDF) are niche players, targeting specialized diagnostic uses. This market taxonomy illustrates how material science advancements and cost-performance trade-offs shape competitive dynamics. PES’s dominance is reinforced by regulatory approvals, while cellulose acetate persists in legacy systems due to familiarity and infrastructure compatibility.

Blood Cell Separation Membrane Segmentation Breakdown9 items

Application

Whole Blood Plasma Separation

Immunochromatographic Diagnosis

Microsomal Diagnostics

Others

Types

for Volumes 10-15 µL

for Volumes 15-50 µL

for Volumes above 50 µL

Regional Insights

Loading chart…

The Blood Cell Separation Membrane market is dominated by North America, which holds the largest regional share, driven by high adoption of advanced medical technologies, robust healthcare infrastructure, and significant R&D investments. The Asia Pacific region, however, is the fastest-growing, fueled by rising healthcare expenditures, a growing geriatric population, and expanding partnerships between global players and local manufacturers. Regional forecast models highlight Asia Pacific’s 15% CAGR, outpacing all other markets.

Regional Drivers & Dynamics13 items

North America (32% share):

High adoption of automated cell separation systems in transplant and oncology therapies.

Strategic investments in biotech ecosystems and FDA regulatory clarity accelerating product approvals.

Europe (28% share):

Mature healthcare systems prioritizing personalized medicine and stem cell research.

EU Horizon 2020 funding boosting innovation in membrane bioreactors.

Asia Pacific (25% share):

Surging demand for affordable diagnostic tools in emerging markets like India and Indonesia.

Government initiatives to modernize healthcare infrastructure and reduce reliance on imports.

Latin America (9% share):

Expanding private-sector partnerships to address gaps in blood bank and transplant services.

Middle East & Africa (6% share):

Increased public funding for hospital modernization and telemedicine integration.

Market growth in Blood Cell Separation Membrane is closely tied to demographic shifts and policy reforms, with Asia Pacific poised to challenge North America’s dominance by 2030. Strategic collaborations and tailored regional supply chains will be critical for stakeholders navigating this competitive landscape.

Competitive Landscape

The Blood Cell Separation Membrane competitive landscape remains moderately consolidated, with a mix of global and regional players. Key participants leverage product innovation and regulatory approvals to differentiate, while pricing pressures and supply chain volatility temper market consolidation. Distribution strategies emphasize direct sales in developed markets and OEM partnerships in emerging regions. Strategic emphasis on ISO 13485 certification and FDA clearance underscores compliance as a core competitive lever.

Strategies across the Blood Cell Separation Membrane market prioritize R&D investment, geographic expansion, and vertical integration to mitigate margin pressures. Companies differentiate through proprietary membrane technologies and customized service models, though rising compliance costs pose a persistent challenge. Partnerships with biotech firms and localization of manufacturing are increasingly deployed to optimize cost structures and accelerate market access.

Cytiva: Focuses on premium pricing and expanding OEM partnerships in diagnostics

Cobetter: Invests in R&D for microfluidic membrane innovations

Fortis Life Sciences: Targets regional expansion in Asia-Pacific via local manufacturing

IW Tremont: Prioritizes cost advantages through vertically integrated production

Advanced Microdevices: Strengthens channel strength with hospital direct distribution

Pall: Expands product portfolio via strategic acquisitions in lab-on-a-chip technologies

Key Blood Cell Separation Membrane Companies8 items

Cytiva

Cobetter

Fortis Life Sciences

IW Tremont

Advanced Microdevices

Axiflow Biotech

Axivasi Chem

Pall

Market Ecosystem

The Blood Cell Separation Membrane ecosystem spans upstream raw material production, midstream membrane manufacturing, and downstream applications in clinical and research settings. Value is generated through innovations in filtration efficiency, biocompatibility, and process optimization, with end-use demand driven by diagnostic, therapeutic, and biotechnology sectors.

Raw material/component suppliers — provide polymers, coatings, and filtration media for membrane fabrication

OEMs / manufacturers — design and produce blood cell separation membranes and associated devices

Technology providers — develop proprietary membrane technologies or separation algorithms for integration

System integrators — assemble membranes into complete blood processing or diagnostic systems

Distributors / channel partners — facilitate supply chain logistics to healthcare and research institutions

Service providers / after-sales — offer installation, maintenance, and technical support for membrane systems

Regulators/standards bodies — enforce compliance with safety, quality, and clinical validation requirements

Control points reside with regulators, who dictate approval pathways, and technology providers, whose IP influences adoption. Dependency risks include material scarcity, stringent validation protocols, and interoperability challenges with existing systems. Switching costs are elevated due to specialized integration needs, while regional differences emerge in regulatory frameworks and healthcare infrastructure maturity.

Recent Industry Insights

The Blood Cell Separation Membrane industry trends over the past 18 months reflect rapid innovation driven by advancements in biotechnology and rising demand for precision medical devices. Notable developments include strategic partnerships, such as Pall Corporation collaborating with biopharma firms to optimize membrane-based cell separation for regenerative medicine. In Mergers & Acquisitions, Thermo Fisher Scientific acquired a specialty membrane startup, expanding its portfolio with nanotechnology-enabled solutions. Product/technology launches have surged, with Haemonetics introducing a next-generation, automated separation system featuring AI-driven efficiency. Regulatory shifts, including the FDA’s 2023 updates on medical device sterility standards, have pushed manufacturers to adopt ISO 13485-compliant production frameworks. Meanwhile, a shift in enterprise trends highlights the adoption of point-of-care separation devices, fueled by decentralized healthcare models. Funding activity remains robust, with venture capital firms investing $45 million in 2024 into startups like MembraneX, which specializes in 3D-printed, biocompatible membranes. Collectively, these trends underscore a market prioritizing scalability, customization, and compliance with evolving global healthcare demands.

Analyst Overview

The Blood Cell Separation Membrane market outlook remains robust, driven by advancements in biopharmaceuticals, rising demand for precision medicine, and expansion of diagnostic applications. Market attractiveness is high, with emerging economies offering untapped growth potential due to improving healthcare infrastructure and increasing prevalence of chronic diseases.

Competitive intensity is moderate, characterized by a mix of established players and niche innovators. Strategic collaborations and R&D investments dominate competitive strategies, while pricing pressures and regulatory compliance pose operational challenges. The innovation landscape is dynamic, with breakthroughs in nanotechnology and bioengineered membranes enhancing separation efficiency and scalability.

Long-term growth is underpinned by the aging global population and expansion of cell-based therapies. However, demand-supply balance faces risks from raw material volatility and production bottlenecks. Key risks include stringent regulatory scrutiny, patent expirations, and geopolitical trade disruptions, which could hinder market consolidation and technological adoption.

12 items

1. Executive Summary

2. Blood Cell Separation Membrane Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Cell Separation Membrane Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Blood Cell Separation Membrane Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Blood Cell Separation Membrane Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Blood Cell Separation Membrane Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Blood Cell Separation Membrane Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Blood Cell Separation Membrane Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Blood Cell Separation Membrane Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Blood Cell Separation Membrane Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Blood Cell Separation Membrane Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Blood Cell Separation Membrane Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Cell Separation Membrane Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Cell Separation Membrane Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Blood Cell Separation Membrane Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Blood Cell Separation Membrane Market Competition by Key Manufacturers

9.1. Global Blood Cell Separation Membrane Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Blood Cell Separation Membrane: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cytiva

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cobetter

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Fortis Life Sciences

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. IW Tremont

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Advanced Microdevices

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Axiflow Biotech

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Axivasi Chem

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Pall

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Cell Separation Membrane Market

Figure 4: Global Blood Cell Separation Membrane Market: Drivers

Figure 5: Global Blood Cell Separation Membrane Market: Challenges

Figure 6: Global Blood Cell Separation Membrane Market: Trends

Figure 7: Global Blood Cell Separation Membrane Market: Opportunity

Figure 8: Global Blood Cell Separation Membrane Market: Restraint

Figure 9: Global Blood Cell Separation Membrane Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Blood Cell Separation Membrane Market Value (USD Million) By Region

Figure 19: Global Blood Cell Separation Membrane Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Blood Cell Separation Membrane Market Value (USD Million) By Region

Figure 27: Global Blood Cell Separation Membrane Market Share (%) By: Regions (2032)

Figure 28: Global Blood Cell Separation Membrane Market Volume (K) By Region

Figure 29: Global Blood Cell Separation Membrane Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Blood Cell Separation Membrane Market Value (USD Million) By Region

Figure 37: Global Blood Cell Separation Membrane Market Share (%) By: Regions (2032)

Figure 38: Global Blood Cell Separation Membrane Market Volume (K) By Region

Figure 39: Global Blood Cell Separation Membrane Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Cell Separation Membrane Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Cell Separation Membrane Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Cell Separation Membrane Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Blood Cell Separation Membrane Market Value (USD Million) By Region

Table 14: Global Blood Cell Separation Membrane Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Blood Cell Separation Membrane Market Volume (K) By Region

Table 31: Global Blood Cell Separation Membrane Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Blood Cell Separation Membrane Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Blood Cell Separation Membrane Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Blood Cell Separation Membrane Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cytiva Basic Information And Sales Area

Table 52: Cytiva. Products Portfolio

Table 53: Cobetter Basic Information And Sales Area

Table 54: Cobetter. Products Portfolio

Table 55: Fortis Life Sciences Basic Information And Sales Area

Table 56: Fortis Life Sciences. Products Portfolio

Table 57: IW Tremont Basic Information And Sales Area

Table 58: IW Tremont. Products Portfolio

Table 59: Advanced Microdevices Basic Information And Sales Area

Table 60: Advanced Microdevices. Products Portfolio

Table 61: Axiflow Biotech Basic Information And Sales Area

Table 62: Axiflow Biotech. Products Portfolio

Table 63: Axivasi Chem Basic Information And Sales Area

Table 64: Axivasi Chem. Products Portfolio

Table 65: Pall Basic Information And Sales Area

Table 66: Pall. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Blood Cell Separation Membrane Market Value (USD Million) By Region

Table 76: Global Blood Cell Separation Membrane Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Blood Cell Separation Membrane Market Volume (K) By Region

Table 93: Global Blood Cell Separation Membrane Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Blood Cell Separation Membrane Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.11 billion
Growth rate	CAGR of 7.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cytiva; Cobetter; Fortis Life Sciences; IW Tremont; Advanced Microdevices; Axiflow Biotech; Axivasi Chem; Pall
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Blood Cell Separation Membrane Segmentation Breakdown9 items

Application

Whole Blood Plasma Separation

Immunochromatographic Diagnosis

Microsomal Diagnostics

Others

Types

for Volumes 10-15 µL

for Volumes 15-50 µL

for Volumes above 50 µL

Regional Insights

Loading chart…

Regional Drivers & Dynamics13 items

North America (32% share):

High adoption of automated cell separation systems in transplant and oncology therapies.

Strategic investments in biotech ecosystems and FDA regulatory clarity accelerating product approvals.

Europe (28% share):

Mature healthcare systems prioritizing personalized medicine and stem cell research.

EU Horizon 2020 funding boosting innovation in membrane bioreactors.

Asia Pacific (25% share):

Surging demand for affordable diagnostic tools in emerging markets like India and Indonesia.

Government initiatives to modernize healthcare infrastructure and reduce reliance on imports.

Latin America (9% share):

Expanding private-sector partnerships to address gaps in blood bank and transplant services.

Middle East & Africa (6% share):

Increased public funding for hospital modernization and telemedicine integration.

Competitive Landscape

Cytiva: Focuses on premium pricing and expanding OEM partnerships in diagnostics

Cobetter: Invests in R&D for microfluidic membrane innovations

Fortis Life Sciences: Targets regional expansion in Asia-Pacific via local manufacturing

IW Tremont: Prioritizes cost advantages through vertically integrated production

Advanced Microdevices: Strengthens channel strength with hospital direct distribution

Pall: Expands product portfolio via strategic acquisitions in lab-on-a-chip technologies

Key Blood Cell Separation Membrane Companies8 items

Cytiva

Cobetter

Fortis Life Sciences

IW Tremont

Advanced Microdevices

Axiflow Biotech

Axivasi Chem

Pall

Market Ecosystem

Raw material/component suppliers — provide polymers, coatings, and filtration media for membrane fabrication

OEMs / manufacturers — design and produce blood cell separation membranes and associated devices

Technology providers — develop proprietary membrane technologies or separation algorithms for integration

System integrators — assemble membranes into complete blood processing or diagnostic systems

Distributors / channel partners — facilitate supply chain logistics to healthcare and research institutions

Service providers / after-sales — offer installation, maintenance, and technical support for membrane systems

Regulators/standards bodies — enforce compliance with safety, quality, and clinical validation requirements

Recent Industry Insights

Analyst Overview

Table of Contents